Diagnosing acute hepatic porphyria (AIP) involves measuring porphobilinogen (PBG) levels in urine during symptomatic episodes, combined with genetic testing to identify HMBS gene alterations that ...

Patients with symptomatic acute hepatic porphyria were found to be at greater risk of accessing long-term sick leave and disability pension compared with the general population, but were not shown to ...

Acute porphyria is a group of uncommon diseases that can cause severe, potentially life-threatening attacks of abdominal pain, nausea, vomiting and paralysis. Liver transplantation is currently the ...

Study results published in PLoS One strongly suggest machine learning can be an effective approach to identify patients who should receive a diagnostic biochemical test to screen for acute hepatic ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window VIENNA -- ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved Givlaari for the treatment of adults with acute hepatic porphyria, a rare genetic disorder that ...

Please provide your email address to receive an email when new articles are posted on . LONDON — Long-term givosiran treatment provided sustained benefit and improved quality of life among patients ...

An acute AIP attack may have numerous clinical manifestations. Abdominal pain is not only the most common symptom, but also is often the first sign of an acute attack. [3] Other common symptoms ...

Up-regulation of hepatic delta-aminolevulinic acid synthase 1 (ALAS1), with resultant accumulation of delta-aminolevulinic acid (ALA) and porphobilinogen, is central to the pathogenesis of acute ...

What is the appropriate treatment for a patient with acute intermittent porphyria and hepatitis B (e-antigen negative) with a normal alanine transaminase and a hepatitis B virus viral load of 45,000 ...

Acute porphyria is a group of uncommon diseases that can cause severe, potentially life-threatening attacks of abdominal pain, nausea, vomiting and paralysis. Liver transplantation is currently the ...

Acute porphyria is a group of uncommon diseases that can cause severe, potentially life-threatening attacks of abdominal pain, nausea, vomiting and paralysis. Liver transplantation is currently the ...